APOLLOMICS, INC.
Last · NasdaqCM$21.32-0.18 (-0.84%)stale · yahoo · 61h ago
Market cap$62.15M2.9M sh
P/E · TTM-2.9fwd -32.8 · eps -7.47 · loss
Beta1.54vs S&P 500
Div yield0.00%annual · TTM
52w range
$10.01$42.12
Volume1.7Ksession
| Revenue | $8.5M |
|---|---|
| Operating income | $-10.9M |
| Net income | $-10.9M |
| Free cash flow | $-10.4M |
| Operating margin | -128.7% |
| Net margin | -128.7% |
| Period | 2025 |
Loading chart…
OpenFilings analyst
Our analyst
From latest 20-F · 2026-04-24
- Operating Cf Burn
- Net Margin Sharply Negative
- Cash Conversion Weak
- Cash Runway Low
- Rd Intensity High
Red flags
- Operating Cf Burn — Negative operating cash flow
- Net Margin Sharply Negative — Net margin -128.7%
- Cash Conversion Weak — Cash conversion (CFO/Rev) -122.0%
- Cash Runway Low — Cash runway ~0.3 years
- Rd Intensity High — R&D/Revenue 65.1%
Press & signals
- GlobeNewswire
Apollomics Announces $10 Million Private Placement Transaction
- GlobeNewswire
Apollomics Receives Nasdaq Deficiency Notice Regarding Minimum Market Value Requirement and Updates Rights for Vebreltinib (APL-101) in Asia
- Satelight
Apollomics Announces $10 Million Private Placement Transaction